Nicola Pozzi Selected Research

Nicola Pozzi Research Topics

Disease

9	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 05/2010
5	COVID-19 08/2021 - 01/2020
5	Thrombosis (Thrombus) 01/2021 - 05/2010
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2010
3	Hemorrhage 01/2020 - 12/2014
2	Critical Illness (Critically Ill) 04/2022 - 03/2019
2	Stroke (Strokes) 12/2018 - 02/2010
2	Sepsis (Septicemia) 03/2012 - 02/2010
1	Macular Degeneration (Age-Related Maculopathy) 10/2022
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Infections 01/2022
1	Neoplasms (Cancer) 01/2022
1	Inflammation (Inflammations) 08/2021
1	Rupture 01/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2020
1	Vascular System Injuries 01/2020
1	Thromboembolism 01/2020
1	Atypical Hemolytic Uremic Syndrome 07/2019
1	Kidney Diseases (Kidney Disease) 11/2017
1	Protein C Deficiency 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2012
1	Bacterial Infections (Bacterial Infection) 03/2012
1	Autolysis 11/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2010

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 01/2021 - 11/2019
4	AutoantibodiesIBA 01/2022 - 05/2010
4	Thrombin FDA Link 01/2020 - 11/2011
3	Complement System Proteins (Complement)IBA 01/2022 - 01/2021
3	Immunoglobulin G (IgG)IBA 08/2021 - 11/2019
3	Proteins (Proteins, Gene)FDA Link 08/2021 - 01/2017
3	Prothrombin (Factor II)IBA 01/2021 - 12/2014
3	Phospholipids (Phosphatides)FDA LinkGeneric 07/2020 - 01/2020
3	EpitopesIBA 07/2020 - 11/2019
3	AnticoagulantsIBA 01/2020 - 01/2018
2	Complement Factor I (C3b Inactivator)IBA 10/2022 - 01/2022
2	Antiphospholipid AntibodiesIBA 01/2021 - 01/2020
2	PhosphatidylserinesIBA 01/2021 - 11/2019
2	AntithrombinsIBA 01/2020 - 01/2018
1	chemotactic factor inactivatorIBA 10/2022
1	Phospholipase A2 ReceptorsIBA 01/2022
1	Complement Factor B (Factor B)IBA 01/2021
1	DisulfidesIBA 01/2021
1	APTIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	PlasticsIBA 01/2021
1	SolutionsIBA 01/2020
1	FibrinIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	AntigensIBA 11/2019
1	Fibrinogen (Factor I)FDA Link 07/2019
1	meizothrombinIBA 12/2018
1	Blood Proteins (Serum Proteins)IBA 11/2017
1	Apolipoprotein L1IBA 11/2017
1	Protein CIBA 01/2017
1	ThrombomodulinIBA 01/2017
1	AutoantigensIBA 12/2016
1	Pharmaceutical PreparationsIBA 12/2014
1	Serine Proteases (Serine Protease)IBA 03/2012
1	von Willebrand FactorIBA 03/2012
1	Bacterial AdhesinsIBA 03/2012
1	DisintegrinsIBA 03/2012
1	ThrombospondinsIBA 03/2012
1	Peptide Hydrolases (Proteases)FDA Link 03/2012
1	ZincIBA 03/2012
1	Metalloproteases (Metalloproteinases)IBA 03/2012
1	EnzymesIBA 11/2011
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 05/2010
1	Peroxynitrous Acid (Peroxynitrite)IBA 02/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2010

Therapy/Procedure

2	Critical Care (Surgical Intensive Care) 04/2022 - 03/2019
2	Therapeutics 01/2022 - 01/2020